Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients after Suboptimal Response to Glatiramer Acetate: Six-Month Interim Analysis of a Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND)

被引：0

作者：

Kresa-Reahl, Kiren ^{[2
]}

Repovic, Pavle ^{[3
]}

Robertson, Derrick ^{[4
]}

Okwuokenye, Macaulay ^{[1
]}

Meltzer, Leslie ^{[1
]}

Mann, Monica ^{[1
]}

机构：

[1] Biogen, Cambridge, MA USA

[2] Providence Multiple Sclerosis Ctr, Portland, OR USA

[3] Swedish Neurosci Inst, Multiple Sclerosis Ctr, Seattle, WA USA

[4] USF Multiple Sclerosis Ctr, Tampa, FL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P6.172

引用

页数：2